Form 4 filed by Reardon Andrew
Reardon Andrew filed this Form 4 on LGND (LIGAND PHARMACEUTICALS INC) with 8 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-06 20:35:36 UTC.
- Accession
- 0001950232-26-000003
- Filer
- CIK 1950232
- Filed
- 2026-10-06
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: LGND · LIGAND PHARMACEUTICALS INC (CIK 886163)
- Reardon Andrew officer (CLO & Secretary)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-02 | M exercised | +340 | $52.27 | 36,854 | D |
| Common Stock | 2026-10-02 | S sold | -833 | $302.5107 | 36,021 | D |
| Common Stock | 2026-10-02 | S sold | -1,976 | $303.5444 | 34,045 | D |
| Common Stock | 2026-10-02 | S sold | -1,535 | $304.5154 | 32,510 | D |
| Common Stock | 2026-10-02 | S sold | -404 | $306.1834 | 32,106 | D |
| Common Stock | 2026-10-02 | S sold | -235 | $307.1911 | 31,871 | D |
| Common Stock | 2026-10-02 | S sold | -17 | $307.74 | 31,854 | D |
| Employee Stock Option (right to buy) derivative | 2026-10-02 | M exercised | -340 | $0 | 29,104 | D |